Karin E. B. Email & Phone Number

San Francisco, Ca, Us

San Francisco Bay Area, Ca, Us

REACH leverages human-centric design thinking to build, implement and operationalize data + AI-powered business, brand, marketing, communication, sales, research and discovery strategies for innovative companies. Recent engagements include:AI-powered pharmaceutical R&D accelerationAI-based fertility predictionAI-powered LLM voice diagnostic for COVIDWe help fill leadership gaps for businesses undergoing rapid transformation. Recent roles filled include:Chief Marketing OfficerHead of Business DevelopmentHead of Corporate & Investor CommunicationsHead of Science BrandingHead of Product DevelopmentReach out to discuss your immediate needs.

Des Plaines, Illinois, Us

SGK solutions combine agile design thinking strategy, creative brand and lean six-sigma consulting to improve brand consistency and speed to market in all major geographies. With more than 3500 employees, SGK is responsible for $350M+ in omni-channel marketing ecosystem management for some of the most well-recognized pharmaceutical and global consumer packaged goods (CPG) brands.Led global business and partnering strategies for SGK Health Consulting Services. Advised pharmaceutical, medical device and nutritional executives on branded design, content, marketing, digital interactive packaging, consumer research and engagement for new and lifecycle product launches. Leveraged lean design thinking to help clients develop smarter, faster, omni-channel engagement solutions that better serve customer health needs. Supported a $450M nutritional acquisition.

San Francisco, California, Us

BOCA is a B2B and B2B2C healthcare and technology strategic communications agency. Advised CEOs and founding members of digital and health technology companies on fundraising approaches, investor and product launch strategies. Helped companies raise $11M in Series A and $20M in Series D funds.

Sunnyvale, Ca, Us

Pharmacyclics is a global $800M pharmaceutical division of Abbvie focused on developing and commercializing small-molecule medicines for the treatment of cancers and immune-mediated diseases. Executive team advisor. Led product, regulatory, investor, M&A, pharmaceutical partner and digital employee culture communications for the launch of IMBRUVICA® (ibrutinib) in blood cancer indications and through Pharmacyclics' $21B acquisition by Abbvie.

Paris, Fr

PUBLICIS/MSLGROUP is a global branding, marketing and PR network with more than $10B revenue and 10,000 employees. Developed brand and communication strategies to promote new and emerging B2B and B2B2C market leaders in healthcare and health technology. Increased the allegiance of existing clients and added new executive-level partners including Acupera, United Allergy Systems, Hearst Health (Zynx Healthcare, First Databank, Homecare Homebase, Milliman Care Guidelines), and Nektar Pharmaceuticals. Helped Series A companies raise > $20M in funds.

REACH is a strategic communications consultancy for health, technology, and consumer finance companies. Engagements included: Website redesign for UCSF’s Office of Health Technology. SEO-optimization of financial service websites with social and digital media content. Marketing communication strategies for financial consultants, a fertility prediction service and fundraising for Health Technology Forum's events and annual conference.

Switzerland 🇨🇭 , Ch

Molecular diagnostics division of Roche, a $57 billion Swiss-based healthcare company with nearly 100,000 employees. Executive team member. Oversaw global internal, external, investor, product launch, partner, M&A and crisis communications. Managed $2M budget. Dual reporting relationship with divisional CEO and head of Roche Diagnostics communications in Basel, Switzerland.Launched first human papilloma virus (HPV) test to identify women with the highest risk of cervical cancer. Managed employee and investor communications for the division through Roche’s $3.4B acquisition of Ventana histopathology medical systems and its $46.8B acquisition of Genentech. Aligned Genentech’s global corporate giving strategy with Roche. Convened a cross-functional team to increase global product branding consistency. Increased marketing competitiveness by re-designing the company’s website, and integrating new digital and social channels that won customers. Advanced and protected global reputation by successfully promoting new product launches and partnerships, and by managing responses to international crises.

Abbott Park, Illinois, Us

Vascular device division of Abbott, a $27 billion global diversified U.S.-based healthcare company with 100,000 employees. Executive team member. Contributed to market leadership positioning for the first everolimus-eluting stent and positioning to introduce the world’s first bio-absorbable stent. Led internal, external, investor, and M&A communications for Abbott Vascular from the start-up phase through its establishment as a leading global multi-billion dollar medical device business, and through its $4.1B co-acquisition of Guidant together with Boston Scientific.

Bachelors, Molecular, Cellular Biology

Bachelors, Journalism